Filtros

Buscador
Año
Chitnis T, Banwell B, Kappos L, Arnold DL, Gucuyener K, Deiva K, Skripchenko N, Cui LY, Saubadu S, Hu W, Benamor M, Le-Halpere A, Truffinet P, Tardieu M; TERIKIDS Investigators. Safety and efficacy of teriflunomide in paediatric multiple sclerosis (TERIKIDS): a multicentre, double-blind, phase 3, randomised, placebo-controlled trial. Lancet Neurol. 2021 Dec;20(12):1001-1011. doi: 10.1016/S1474-4422(21)00364-1. PubMed PMID: 34800398.
AÑO: 2021; IF: 59.935
Fernandez O, Montalban X, Aladro Y, Alonso A, Arroyo R, Calles C, Castillo-Trivino T, Comabella M, Costa-Frossard L, Forero L, Ginestal R, Landete L, Llaneza M, Llufriu S, Martinez-Gines ML, Meca-Lallana J, Mendibe M, Oreja-Guevara C, Oterino A, Prieto JM, Ramio-Torrenta L, Romero-Pinel L, Tellez N, Rodriguez-Antiguedad A. 13th Post-ECTRIMS Meeting: review of the new developments presented at the 2020 ECTRIMS Congress (I). Rev Neurol. 2021 Jun 1;72(11):397-406. doi: 10.33588/rn.7211.2021172. English, Spanish. PubMed PMID: 34042168.
AÑO: 2021; IF: 1.235
Otero-Romero S, Rodriguez-Garcia J, Vilella A, Ara JR, Brieva L, Calles C, Carmona O, Casanova V, Costa-Frossard L, Eichau S, Garcia-Merino JA, Garcia-Vidal C, Gonzalez-Platas M, Llaneza M, Martinez-Gines M, Meca-Lallana JE, Prieto JM, Rodriguez-Antiguedad A, Tintore M, Blanco Y, Moral E; en nombre del Grupo de enfermedades desmielizantes de la SEN. Recommendations for vaccination in patients with multiple sclerosis who are eligible for immunosuppressive therapies: Spanish consensus statement. Neurologia (Engl Ed). 2021 Jan-Feb;36(1):50-60. doi: 10.1016/j.nrl.2020.02.006. Epub 2020 Jun 17. English, Spanish. PubMed PMID: 32561334.
AÑO: 2021; IF: 3.9
Walo-Delgado PE, Monreal E, Medina S, Quintana E, Sainz de la Maza S, Fernandez-Velasco JI, Lapuente P, Comabella M, Ramio-Torrenta L, Montalban X, Midaglia L, Villarrubia N, Carrasco-Sayalero A, Rodriguez-Martin E, Roldan E, Meca-Lallana J, Alvarez-Lafuente R, Masjuan J, Costa-Frossard L, Villar LM. Role of B Cell Profile for Predicting Secondary Autoimmunity in Patients Treated With Alemtuzumab. Front Immunol. 2021 Oct 8;12:760546. doi: 10.3389/fimmu.2021.760546. eCollection 2021. PubMed PMID: 34691084; PubMed Central PMCID: PMC8531491.
AÑO: 2021; IF: 8.786
Meca-Lallana JE, Prefasi D, Perez-Miralles F, Forero L, Sepulveda M, Calles C, Martinez-Gines ML, Gonzalez-Suarez I, Boyero S, Romero-Pinel L, Sempere AP, Meca-Lallana V, Querol L, Costa-Frossard L, de Castro-Trapiello H, Canal N, Maurino J. Perception of Stigma in Patients with Neuromyelitis Optica Spectrum Disorder. Patient Prefer Adherence. 2021 Apr 12;15:713-719. doi: 10.2147/PPA.S305707. eCollection 2021. PubMed PMID: 33880015; PubMed Central PMCID: PMC8052114.
AÑO: 2021; IF: 2.314